| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
3
3
5
3
3
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
A+
(Buy)
|
#23 in Health
U.S. News evaluated 38 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 37.93 percent over the past year, 18.90 percent over the past three years, 9.11 percent over the past five years, and 8.83 percent over the past decade.
| Trailing Returns | Updated 05.31.2013 |
|---|---|
| Year to date | 21.4% |
| 1 Year | 37.9% |
| 3 Years (Annualized) | 18.9% |
| 5 Years (Annualized) | 9.1% |
| 10 Years (Annualized) | 8.8% |
Summary
The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities issued by foreign companies and governments engaged primarily in the health care-related industry. It invests primarily in equity securities, securities convertible into equity securities, and depositary receipts. The fund may invest in the securities of issuers of all capitalization sizes; however, the fund may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.
Fees
Fees are Below Average compared to funds in the same category.
Invesco Global Health Care Fund has an expense ratio of 1.17 percent.
Risk
Risk is Average compared to funds in the same category according to Morningstar.
